dc.contributor.author | Fagnano, E | |
dc.contributor.author | Pendharkar, S | |
dc.contributor.author | Colton, M | |
dc.contributor.author | Jones, PN | |
dc.contributor.author | Sallan, MC | |
dc.contributor.author | Klymenko, T | |
dc.contributor.author | Braun, A | |
dc.contributor.author | Klein, C | |
dc.contributor.author | Honeychurch, J | |
dc.contributor.author | Cheadle, EJ | |
dc.contributor.author | Illidge, TM | |
dc.date.accessioned | 2023-11-16T15:31:42Z | |
dc.date.available | 2023-11-16T15:31:42Z | |
dc.identifier.issn | 2296-634X | |
dc.identifier.uri | https://qmro.qmul.ac.uk/xmlui/handle/123456789/91997 | |
dc.format.extent | 1270398 - ? | |
dc.publisher | Frontiers | en_US |
dc.relation.ispartof | Frontiers in Cell and Developmental Biology | |
dc.rights | Attribution 3.0 United States | * |
dc.rights.uri | http://creativecommons.org/licenses/by/3.0/us/ | * |
dc.subject | Cancer | en_US |
dc.subject | Lymphoma | en_US |
dc.subject | Hematology | en_US |
dc.subject | Rare Diseases | en_US |
dc.subject | Biotechnology | en_US |
dc.subject | 2.1 Biological and endogenous factors | en_US |
dc.subject | 2 Aetiology | en_US |
dc.subject | Cancer | en_US |
dc.title | Stromal cell inhibition of anti-CD20 antibody mediated killing of B-cell malignancies | en_US |
dc.type | Article | en_US |
dc.identifier.doi | 10.3389/fcell.2023.1270398 | |
pubs.notes | Not known | en_US |
pubs.volume | 11 | en_US |
qmul.funder | Lamin B1-mediated genomic instability in leukaemia and lymphoma::Blood Cancer UK | en_US |